Category Added in a WPeMatico Campaign
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMLX
New York, New York – Newsfile Corp. – March 9, 2024 – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) between November 11, 2022 and November 8, 2023, both dates inclusive (the “Class Period”), of the important […]